Liting Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Cancer-related gene regulation
Papers in
-
- Cancer-related molecular mechanisms research 17
-
- RNA modifications and cancer 12
- RNA Research and Splicing 5
- Viral Infectious Diseases and Gene Expression in Insects 4
- Circular RNAs in diseases 4
- RNA Interference and Gene Delivery 3
- Co-authors
- Guiyuan Li (12 shared papers)Can Jie Guo (13 shared papers)Wei Xiong (12 shared papers)Xiaoling Li (11 shared papers)Yanyan Tang (11 shared papers)Zhaoyang Zeng (10 shared papers)Fang Xiong (9 shared papers)Shanshan Zhang (9 shared papers)
- Journals
- Journal of Cancer (4 papers)CNS Neuroscience & Therapeutics (3 papers)Frontiers in Oncology (3 papers)Oncotarget (3 papers)Molecular Cancer (3 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Liting Yang
65 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 139
- Cancer Research 1.1k
- Molecular Biology 1.2k
- Oncology 196
- Immunology 140
- Tourism, Leisure and Hospitality Management 11
Countries citing papers authored by Liting Yang
This map shows the geographic impact of Liting Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liting Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liting Yang more than expected).
Fields of papers citing papers by Liting Yang
This network shows the impact of papers produced by Liting Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liting Yang. The network helps show where Liting Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liting Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 156 | |
| 2 | 2018 | 146 | |
| 3 | 2018 | 146 | |
| 4 | 2018 | 136 | |
| 5 | 2021 | 126 | |
| 6 | 2019 | 118 | |
| 7 | 2017 | 105 | |
| 8 | 2017 | 92 | |
| 9 | 2019 | 91 | |
| 10 | 2021 | 85 | |
| 11 | 2023 | 84 | |
| 12 | 2016 | 81 | |
| 13 | 2021 | 70 | |
| 14 | 2016 | 66 | |
| 15 | 2022 | 61 | |
| 16 | 2017 | 54 | |
| 17 | 2023 | 44 | |
| 18 | 2021 | 35 | |
| 19 | 2016 | 31 | |
| 20 | 2023 | 31 |
About Liting Yang
Liting Yang is a scholar working on Cancer Research, Molecular Biology, Immunology, General Economics, Econometrics and Finance and Cell Biology, having authored 67 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), RNA modifications and cancer (12 papers), RNA Research and Splicing (5 papers), CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Circular RNAs in diseases (4 papers), Immune cells in cancer (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations), Oncology (196 citations), Immunology (140 citations) and Tourism, Leisure and Hospitality Management (11 citations). Liting Yang has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Can Jie Guo, Wei Xiong, Xiaoling Li, Yanyan Tang, Zhaoyang Zeng, Fang Xiong, Shanshan Zhang, Yong Li and Zhaojian Gong. Their work appears in journals such as Journal of Cancer, CNS Neuroscience & Therapeutics, Frontiers in Oncology, Oncotarget and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.